Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Effective management of hyperandrogenism in young women requires accurate diagnosis and tailored treatment.

A woman's excess male hormone symptoms were caused by a rare benign tumor in her ovary.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

Early treatment is important for better hair regrowth in elderly women with hair loss.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.